Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Transcat Inc is an industrial distribution business based in the US. Transcat shares (TRNS) are listed on the NASDAQ and all prices are listed in US Dollars. Transcat employs 812 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $56.65 |
|---|---|
| 52-week range | $55.40 - $101.05 |
| 50-day moving average | $66.23 |
| 200-day moving average | $77.40 |
| Wall St. target price | $82.00 |
| PE ratio | 37.7667 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.50 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $56.65 from 2022-07-01
| 1 week (2022-06-24) | -7.96% |
|---|---|
| 1 month (2022-06-02) | -13.46% |
| 3 months (2022-03-30) | N/A |
| 6 months (2022-01-03) | -37.69% |
| 1 year (2021-07-02) | -1.55% |
|---|---|
| 2 years (2020-07-02) | 124.18% |
| 3 years (2019-07-03) | 119.40% |
| 5 years (2017-06-30) | 366.26% |
Valuing Transcat stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Transcat's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Transcat's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 38x. In other words, Transcat shares trade at around 38x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Transcat's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $24.6 million.
The EBITDA is a measure of a Transcat's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $205 million |
|---|---|
| Operating margin TTM | 7.34% |
| Gross profit TTM | $58.4 million |
| Return on assets TTM | 6.07% |
| Return on equity TTM | 14.11% |
| Profit margin | 5.55% |
| Book value | $11.45 |
| Market capitalisation | $427.5 million |
TTM: trailing 12 months
We're not expecting Transcat to pay a dividend over the next 12 months.
Transcat's shares were split on a 2:1 basis on 22 July 1997. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Transcat shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Transcat shares which in turn could have impacted Transcat's share price.
Over the last 12 months, Transcat's shares have ranged in value from as little as $55.4 up to $101.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Transcat's is 0.8376. This would suggest that Transcat's shares are less volatile than average (for this exchange).
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.